Author: healthylife7

Confluence Health earns perinatal care designation – Quad City Herald Skip to main content

U.S. Canine Separation Anxiety Market Climbs from USD 27.7 Press release U.S. Canine Separation Anxiety Market Climbs from USD 27.7 billion to USD 49.4 billion by 2036 at 5.4% CAGR as Orion Wins FDA Nod for Tessie 08-03-2026 09:02 PM CET | Food & BeveragePress release from: Fact.MR ROCKVILLE, MD /August 3, 2026 – According…

Written by Mandy French and Jase Peeples — Fact checked by Jill Seladi-Schulman, Ph.D

On July 16, 2026, the Food and Drug Administration (FDA) approved Lipfendra (enlicitide), the first ever oral PCSK9 inhibitor , for the treatment of high cholesterol (hypercholesterolemia) and heterozygous familial hypercholesterolemia

The next phase introduces flexible new studio concepts, including Pilates, strength, boxing, and recovery, bringing premium fitness experiences to more members at Crunch’s affordable price point. 

Hilton has announced the signing of three lifestyle properties, including a Curio Collection by Hilton hotel in Phuket and two Tapestry Collection by Hilton properties in Chiang Mai and the Maldives, further expanding the company’s lifestyle brand portfolio in South East Asia. The hotels in Thailand will join a growing lifestyle portfolio that includes the…

Authorities in the US state of Michigan say that they have confirmed the deaths of two people in a cyclospora outbreak, the first fatal cases of a disease related to the microscopic parasite recorded in the United States

When the FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025 (with the launch following in early January 2026), the response was immediate. Patients who had spent months dreading their weekly injections suddenly had a new question for their doctors, and doctors suddenly had a much harder question…

As record heat waves continue, the nutritional status of Koreans is showing a worsening trend

JACKSONVILLE, Fla. – Complete Health Partners Holdings has agreed to pay $14.1 million to settle allegations that it caused false diagnosis codes to be submitted to boost payments from the Medicare Advantage program, the Department of Justice said